Knowledge Base

How to check the compliance of subjects?

16 January 2024
3 min read

The drug packaging box sent to the subject will be returned to the investigator by the subject after the end of the trial. The subject should be emphasized to return all drug packaging, including the packaging of used up and remaining drugs. This can help researchers to count the actual situation of patients taking drugs. If the test drug is a tablet or capsule, it should be packaged in aluminum foil or weekly, so that when the package is returned to the investigator, the used up and remaining, missed or lost drugs and the date can be clearly displayed. If the tablet drugs are put into the bottle, count the remaining drugs after the drugs are returned to determine how many drugs are left, and then calculate how many drugs are taken by the patient. If it is a liquid drug, you should know how many drugs are in the bottle in advance. After the treatment, the volume of the remaining drugs was measured and the amount used by the patients was obtained. Sometimes it is difficult to measure the compliance of patients. For example, when drugs are packed in glass vials, the compliance can be measured by comparing the weight of containers before and after treatment. Another way to measure patient compliance is to detect the level of trial drugs in the subjects' blood samples. This can ensure that the subject took the trial drug and knew whether it reached the therapeutic level in the blood. As for the more accurate method of measuring compliance (especially in single dose trials), a small amount of non effective dye can be added to the trial drugs, and the patient's urine sample can be taken at each follow-up. Because the dye is discharged by the prototype and makes the urine fluorescent under UV light, this simple and fast method can be used to check whether there is dye in the urine. Of course, this method can only check the recent medication situation of patients and cannot determine the consistent compliance of patients. A microchip can also be installed in the drug bottle cap to record the date and time when the cap is opened each time. Although this method accurately records the time and date when the patient opened the drug bottle, it is not sure that the patient must have taken the trial drug. Carefully asking the subject about medication is another effective way to check compliance. Of course, no method of checking compliance is perfect. Usually, multiple methods are used at the same time to determine the compliance of subjects in the trial.

Corbus Pharma Secures US FDA Approval for Phase 1 Trial of its Novel αvβ8 Antibody, CRB-601
Latest Hotspot
3 min read
Corbus Pharma Secures US FDA Approval for Phase 1 Trial of its Novel αvβ8 Antibody, CRB-601
16 January 2024
Corbus Pharmaceuticals Holdings, Inc., focused on precision oncology, announced FDA approval for its CRB-601 drug application.
Read →
Exploring the Latest PD-L1/SIRPα Bispecific Antibody Deal by Elpiscience Biopharma: A Guide to Rapidly Accessing Transaction Insights
DrugDeal Decode
5 min read
Exploring the Latest PD-L1/SIRPα Bispecific Antibody Deal by Elpiscience Biopharma: A Guide to Rapidly Accessing Transaction Insights
16 January 2024
Elpiscience Biopharma and Astellas Pharma have teamed up in a deal for the BiME® platform, advancing two drugs, ES019 and a second molecular project.
Read →
Constant Therapeutics Reveals Initial Participant Receives Treatment in Stage 2 Study for Stroke Rehab using Drug TXA127
Latest Hotspot
3 min read
Constant Therapeutics Reveals Initial Participant Receives Treatment in Stage 2 Study for Stroke Rehab using Drug TXA127
16 January 2024
Constant Therapeutics LLC, specializing in biopharmaceuticals, announced the first patient dosed in their Phase 2 trial of TXA127, a peptide therapy aimed at improving post-stroke recovery.
Read →
Expand your analysis with a 360° industry overview!
Bio Sequence
3 min read
Expand your analysis with a 360° industry overview!
16 January 2024
Gain instant access to industry insights for your sequence of interest, with exportable reports summarizing length and identity distribution, drug and patent activity, IP and literature trends, and more!
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.